Genetix Pharmaceuticals Announces Global Clinical Plans To Treat Adrenoleukodystrophy (ALD)

Links shared publicly online about this topic.

  • 1,615
    total visits

Genetix Pharmaceuticals Announces Global Clinical Plans To Treat Adrenoleukodystrophy (ALD)

medicalnewstoday.com —

Genetix Pharmaceuticals, a leader in gene therapy of somatic stem cells, announced the company's clinical program to treat Adrenoleukodystrophy (ALD). The company is developing a gene therapy pro

View full resource at medicalnewstoday.com

Tags: Pharma, Stem Cell, Genes

  • Share

Most Recently Shared on November 9, 2009 at 3:37 pm By:

mnt_pediatrics MNT Pediatrics News

Genetix Pharmaceuticals Announces Global Clinical Plans To Treat Adrenoleukodystrophy (ALD): Genetix Pharmaceut.. http://bit.ly/4rxCGo

3 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Neurology News MNT Neurology News

Advertisement